“Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants” (2023) SKIN The Journal of Cutaneous Medicine, 7(4), p. s227. doi:10.25251/skin.7.supp.227.